[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@HottestStockNow Hottest Stocks NowHottest Stocks Now posts on X about $adct, $kymr, kymera, renault the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXXXX% stocks XXXXX% cryptocurrencies XXXX% exchanges XXXX% automotive brands XXX% countries XXXX% fashion brands XXXX%
Social topic influence $adct 2.9%, $kymr #59, kymera #32, renault #336, ford 2.9%, $rnlsy #1, $mrx 1.45%, japan 1.45%, reduce 1.45%, $fenc XXXX%
Top assets mentioned ADC Therapeutics SA (ADCT) Kymera Therapeutics, Inc. Common Stock (KYMR) Metrix Coin (MRX) Biogen Inc (BIIB) Johnson & Johnson (JNJ) Hormel Foods Corp (HRL) Royalty Pharma plc Class A Ordinary Shares (RPRX) Denali Therapeutics Inc. Common Stock (DNLI) BRP Inc. Common Subordinate Voting Shares (DOOO) AbbVie Inc (ABBV) Somnigroup International Inc. (SGI) Legia Warsaw Fan Token (LEG) Huntsman Corporation (HUN) Jazz Pharmaceuticals, Inc. (JAZZ) Victoria's Secret & Co. (VSCO) CG Oncology, Inc. Common stock (CGON) Frontline Ltd. (FRO) Regeneron Pharmaceuticals Inc (REGN) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) ALEX Lab (ALEX) Alexander & Baldwin, Inc. (ALEX) Novartis AG (NVS)
Top posts by engagements in the last XX hours
"Marex: Insider Confidence $MRX #MarexGroup #Marex"
X Link 2025-10-13T11:20Z 2718 followers, XXX engagements
"Fennec Pharmaceuticals: Investigator-Initiated Clinical Study of PEDMARK in Japan to Reduce Cisplatin-Induced Hearing Loss Met Primary Endpoint $FENC $FRX.CA #FennecPharmaceuticals #FennecPharma #Fennec"
X Link 2025-12-02T12:24Z 2718 followers, XX engagements
"ADC Therapeutics to reveal update on LOTIS-7 Phase 1b open-label clinical trial testing safety and efficacy of ZYNLONTA + glofitamab (COLUMVI) combo in patients with relapsed or refractory diffuse large B-cell lymphoma $ADCT #ADCTherapeutics #ADCTx"
X Link 2025-12-02T23:43Z 2718 followers, XXX engagements
"ADC Therapeutics: New Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Supports Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma $ADCT #ADCTherapeutics #ADCTx"
X Link 2025-12-03T13:00Z 2718 followers, XXX engagements
"Eisai and Biogen: Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment to moderate Alzheimers disease by up to XXX years in low-amyloid group who started treatment at early stage $BIIB #Biogen #Eisai"
X Link 2025-12-03T23:49Z 2718 followers, XXX engagements
"Johnson & Johnson: INLEXZO (gemcitabine intravesical system) delivers XX percent disease-free survival at one year in BCG-unresponsive high-risk papillary-only NMIBC $JNJ #JNJNews #JohnsonJohnson"
X Link 2025-12-06T20:14Z 2718 followers, XX engagements
"Key Date Approaching for Ocean Power Technologies Shareholders $OPTT #OceanPowerTechnologies #OceanPowerTech #OceanPower"
X Link 2025-12-03T22:51Z 2717 followers, XXX engagements
"Hormel Foods reports fourth quarter and full-year fiscal 2025 results - Sees Clear Path for Profitable Growth in Fiscal 2026 $HRL #HormelFoods #Hormel"
X Link 2025-12-04T12:04Z 2718 followers, XX engagements
"Royalty Pharma and Denali Therapeutics Ink $275Mi Royalty Funding Deal $RPRX #RoyaltyPharma $DNLI #DenaliTherapeutics #DenaliTx #Denali"
X Link 2025-12-04T12:35Z 2718 followers, XXX engagements
"Kymera Therapeutics to reveal data from the BroADen Phase 1b clinical trial evaluating KT-621 its oral STAT6 degrader in patients with moderate to severe atopic dermatitis (AD) $KYMR #KymeraTherapeutics #KymeraTx #Kymera"
X Link 2025-12-05T22:01Z 2718 followers, XXX engagements
"Kymera Therapeutics Reveals Data from BroADen Phase 1b Clinical Trial Evaluating KT-621 in Patients with Moderate to Severe Atopic Dermatitis $KYMR #KymeraTherapeutics #KymeraTx #Kymera"
X Link 2025-12-08T12:21Z 2718 followers, XXX engagements
"G-III Apparel Reports Third Quarter Fiscal 2026 Results - Raises GAAP and Non-GAAP Net Income Per Diluted Share Guidance; Introduces First Ever Quarterly Dividend of $XXXX Per Share $GIII #GIIIApparel"
X Link 2025-12-09T12:16Z 2718 followers, XX engagements
"BRP to Reveal Its Mission XX (M28) Strategic Plan $DOOO $DOO.CA #BRPInc #BRP #BRPNews"
X Link 2025-10-02T20:41Z 2718 followers, XX engagements
"AbbVie: Phase X ECLIPSE Data Show Atogepant (AQUIPTA) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine $ABBV #AbbVie #Migraine"
X Link 2025-12-01T09:49Z 2718 followers, XX engagements
"Somnigroup Proposes to Acquire Leggett & Platt in All-Stock Transaction $SGI #Somnigroup $LEG #LeggettPlatt"
X Link 2025-12-01T11:48Z 2718 followers, XX engagements
"Huntsman expects fourth quarter 2025 adjusted EBITDA to be at the low end of its guidance range $HUN #Huntsman"
X Link 2025-12-01T22:36Z 2717 followers, XX engagements
"First U.S. Commercial Sale of KOMZIFTI Triggers $135M Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin $KURA #KuraOncology #KyowaKirin"
X Link 2025-12-02T13:07Z 2718 followers, XXX engagements
"Jazz Pharmaceuticals to reveal Phase X HERIZON-GEA-01 trial results for Ziihera in first-line HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA) $JAZZ #JazzPharmaceuticals #JazzPharma"
X Link 2025-12-03T01:12Z 2718 followers, XX engagements
"Regentis Biomaterials to Debut on NYSE American $RGNT #RegentisBiomaterials #Regentis"
X Link 2025-12-04T00:46Z 2717 followers, XX engagements
"Bayer Starts Phase X Study for Treatment of Patients with Alport Syndrome - Milestone payment to Evotec expected upon first dosing of first study participant in early 2026 $EVO #Evotec #EVT $BAYRY $BAYZF #BayerAG #Bayer #BAYN"
X Link 2025-12-04T11:22Z 2717 followers, XXX engagements
"Victorias Secret & Reports Third Quarter Results - Raises Fiscal Year 2025 Net Sales Operating Income and Earnings Guidance $VSCO #VictoriasSecret"
X Link 2025-12-05T12:08Z 2718 followers, XXX engagements
"CG Oncology: New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer $CGON #CGOncology"
X Link 2025-12-05T13:38Z 2717 followers, XXX engagements
"Genmab: Phase X Data from EPCORE FL-1 Trial Shows Clinical Benefit of EPKINLY (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma $GMAB #Genmab"
X Link 2025-12-07T17:54Z 2717 followers, XXX engagements
"Regeneron Pharmaceuticals: Lynozyfic (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses Supporting Rationale as a Potential Foundation in Frontline Treatment $REGN #Regeneron"
X Link 2025-12-08T02:20Z 2717 followers, XXX engagements
"SEC Notifies MSP Recovery $MSPR #MSPRecovery"
X Link 2025-12-08T03:12Z 2717 followers, XXX engagements
"Galapagos: New data from Phase X ATALANTA-1 study shows GLPG5101 offers timely treatment with low rates of high-grade toxicities durable responses for patients with relapsed or refractory mantle cell lymphoma (MCL) $GLPG #GalapagosNV #Galapagos"
X Link 2025-12-08T10:55Z 2717 followers, XXX engagements
"Recursion: Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Show Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks $RXRX #Recursion"
X Link 2025-12-08T12:51Z 2718 followers, XXX engagements
"Alexander & Baldwin to be acquired for $XXXXX per share in an all-cash transaction $ALEX #AlexanderBaldwin"
X Link 2025-12-08T22:53Z 2717 followers, XX engagements
"Renault Group and Ford ink strategic partnership for passenger and commercial vehicles starting with two affordable electric cars in Europe $F #FordMotor #Ford $RNLSY #RenaultGroup #RenaultSA #Renault #RNO"
X Link 2025-12-09T10:53Z 2718 followers, XX engagements
"Ford reveals the next phase of its European transformation $F #FordMotor #Ford $RNLSY #RenaultGroup #RenaultSA #Renault #RNO"
X Link 2025-12-09T10:55Z 2718 followers, XX engagements
"Novartis: X in X metastatic breast cancer patients treated with Kisqali remain progression-free beyond X years $NVS #Novartis"
X Link 2025-12-09T12:35Z 2718 followers, XX engagements
"Cardinal Infrastructure Group to Debut on Nasdaq $CDNL #CardinalInfrastructure"
X Link 2025-12-10T01:18Z 2718 followers, XX engagements
"JM Group to Debut on NYSE American $JMG #JMGroup"
X Link 2025-12-10T01:20Z 2718 followers, XX engagements